IRCT20170820035796N2招募中3 期
The explanation of the causes of high blood pressure and its therapies in Persian medicine and the effect of Lemongrass herbal product in primary blood pressure control
Sari University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 75 years(—)
- 性别
- All
入选标准
- •Men and women 30-75 years old
- •??Systolic blood pressure greater than or equal to 140, and diastolic blood pressure greater than or equal to 90 mmHg being treated with blood pressure medication (one to three drugs based on the protocol), but the patient’s blood pressure is uncontrolled
- •At least one month has elapsed since the onset of drug use
- •Have informed consent to participate in the study.
排除标准
- •Blood pressure equal to or greater than 110/180 at the start of the study or during intervention
- •History of secondary hypertension
- •Major symptoms of major organ damage (such as renal failure, congestive heart failure, myocardial infarction, or cerebrovascular accidents) During the 6 months before the study
- •The presence of any type of cardiac arrhythmia (such as second- or third-degree blocks)
- •Symptomatic valvular disease
- •Liver dysfunction
- •Type 1 and type 2 diabetic patients with impaired renal and liver function to the extent that clinically significant (ie more than 1.5 times the maximum normal creatinine and alanine aminotransferase more than 3 times the normal maximum)
- •Low platelet count More than 100,000 per microliter of blood
- •History of treated or untreated malignancies
- •Potassium greater than 1.5 or less than 3.5 mg / L in the first visit
- •History of hypothyroidism or hyperthyroidism
- •Pregnancy and lactation
- •The presence of any medical or surgical disorder that could interfere with the study.
研究者
相似试验
已完成
不适用
Analysis of factors associated with blood pressure reduction and serum potassium elevation in hypertensive patients treated with esaxerenone (CS-3150) -Integrated analysis from CS-3150 phase 3 studiesHypertensionJPRN-UMIN000047026Daiichi Sankyo Co., Ltd.1,472
已完成
Unknown
Analysis of factors associated with blood pressure reductions in hypertensive patients treated with esaxerenone -Integrated analysis from esaxerenone clinical studiesHypertensionJPRN-UMIN000051525Daiichi Sankyo Co., Ltd.493
尚未招募
不适用
Evaluation of etiological factor for HypertensioCTRI/2021/11/038063PT KHUSHILAL SHARMA GOVT AUTO AYURVED COLLEGE INSTITUTE BHOPAL MP
招募中
Unknown
The effects of excessive sitting on blood pressure and renal artery blood flow.JPRN-UMIN000052730iigata University of Health and Welfare16
已完成
不适用
To clarify the association between blood pressure measured by a new wearable wrist-type blood pressure monitoring device (WBPM) and left ventricular hypertrophyHypertensionJPRN-UMIN000040939Jichi Medical University School of Medicine50
